Latest acquisitions in the Medical Devices market

30/10/2020
Diego Gutiérrez
Latest acquisitions in the Medical Devices market

The market for medical devices is a mature market: the mergers and acquisitionsincreased significantly in 2014 and indicate that they will continue to grow in 2019 and beyond. 

Baker Tilly analyses which are the most important mergers and acquisitions in the market. But first, the sector is explained. Medical devices refers to any instrument, apparatus, appliance, implement, machine, implant... Medical devices are essential for the safe and effective prevention, diagnosis, treatment and rehabilitation of disease and illness. 

Johnson & Johnson and Auris Health  

Latest acquisitions in the Medical Devices market

Multinational Johnson & Johnson has reached an agreement to buy Auris Health for $3.4 billion with the aim of accelerating its entry into robotics, simplifying surgery, boosting efficiency, reducing complications and improving patient outcomes.

Auris Health is a technology developer specialising in lung cancer treatment, as part of its creation of a digitally connected ecosystem in the healthcare sector and also positions itself as a leader in surgical procedures. 

Johnson & Johnson is an American multinational manufacturer of medical devices, pharmaceuticals, personal care, fragrances and baby products founded in 1886. 

Siemens Healthineers and Corindus 

Siemens Healthineers and Corindus 

Siemens Healthineers has signed a merger agreement with the American company Corindus Vascular Robotics, a world leader in technology for robotic-assisted vascular interventions. Thanks to which it is positioned as one of the main leaders in the field of robotic vascular interventions and minimally invasive procedures. 

The acquisition is aimed at simplifying the current challenges faced by practitioners in their daily practice, as robotic-assisted minimally invasive procedures can reduce treatment times, increase treatment accuracy, raise levels of standardisation in clinical procedures and ultimately improve clinical outcomes, which represent the strategic focus of the Advanced Therapies business segment. 

En Baker Tilly Tech M&Asomos expertos en la sale of all or part of their businesses Shall we talk? 

Lastest news

Webinar | Cómo maximizar el valor de tu empresa antes de vender

INFORMACIÓN IMPORTANTE: La inscripción y participación en los webinars es totalmente anónima para terceros Cómo maximizar el valor de tu empresa antes de vender Maximizar el valor de tu empresa antes de vender es, casi siempre, el trabajo más rentable que puede hacer...

The State of technology M&A in Spain | May 2026 Analysis

El M&A tecnológico en España registró en mayo de 2026 36 operaciones identificadas con un importe agregado conocido de aproximadamente 720,7 millones de euros. La cifra es una referencia mínima: 13 transacciones no hicieron público su importe. El mes combinó...

Notable technology M&A deals in Spain | Analysis: April 2026

The market for the sale and acquisition of technology companies in Spain once again saw particularly brisk activity in April 2026. The month saw significant deals in vertical software, cybersecurity, cloud computing, payments, artificial intelligence, telecommunications...

What does Constellation Software teach us about real value in tech M&A?

An analysis by Diego Gutiérrez Zarza, Partner at Baker Tilly Tech M&A For years, growth was enough to build value in a technology company. That is no longer the case. The market continues to pay a premium for good software companies, but it no longer rewards growth for its own sake...

Strategic Guide: AI and Valuation Multiples in Tech M&A in 2026

An analysis by Diego Gutiérrez Zarza, Partner at Baker Tilly Tech M&A To help you understand the current market for buying and selling technology companies, we have summarised the key points of our latest research in this quick-reference guide. How are...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

    On which topic would you like to receive information?

    Request for information

    If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

    Or if you prefer, call us at:

    +34 946 42 41 42